IRIDEX Corporation

IRIX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jul 2026 Apr 2026 Jan 2026 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-1.3M $-524.0K $-184.0K $-1.6M $-994.0K $-1.7M $-834.0K $-1.9M
Depreciation & Amortization $86.0K $100.0K $151.0K $110.0K $127.0K $135.0K $135.0K $137.0K
Depreciation — — — — — — — —
Amortization $79.0K $80.0K $80.0K $80.0K $79.0K $84.0K $82.0K $84.0K
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $174.0K $-1.3M $589.0K $-1.2M $-397.0K $-1.1M $-1.2M $-3.1M
Investing Activities
Capital Expenditures $50.0K $101.0K $106.0K $13.0K $13.0K $11.0K $9.0K $1.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-50.0K $-101.0K $-106.0K $-13.0K $-13.0K $-11.0K $-9.0K $-1.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-38.0K $-1.0K $-27.0K $-34.0K $-14.0K $6.0M $-218.0K $2.8M
Net Change in Cash $85.0K $-1.4M $455.0K $-1.2M $-466.0K $4.9M $-1.5M $-251.0K
Free Cash Flow $124.0K $-1.4M $483.0K $-1.2M $-410.0K $-1.2M $-1.2M $-3.1M
← Newer Page 1 of 8 Older →